Evidence map›Paper›PMID 25304508›Full record

ArticleApplied and environmental microbiology2015

Use of adaptive laboratory evolution to discover key mutations enabling rapid growth of Escherichia coli K-12 MG1655 on glucose minimal medium.

Ryan A LaCroix, Troy E Sandberg, Edward J O'Brien, Jose Utrilla, Ali Ebrahim, Gabriela I Guzman, Richard Szubin, Bernhard O Palsson, Adam M Feist

Open access · bronzeAbstract read
In one paragraph

Article in Applied and environmental microbiology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 146 papers.

0numbers the graph read from it
0cells of the map it votes in
146citing papers in PubMed
6.0field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

146 citing papers in PubMed, 271 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Adaptive Laboratory Evolution inMicroorganisms · 2026
    Review
  6. Article
  7. Article
  8. Transcriptome Profiling ofAntibiotics (Basel, Switzerland) · 2026
    Article
  9. Article
  10. Aerobicity stimulon iniScience · 2026
    Article
  11. Article
  12. Advances in adaptive laboratory evolution applications forSynthetic and systems biotechnology · 2025
    Review
  13. Phage Resistance ModulatesAntibiotics (Basel, Switzerland) · 2025
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Transcriptome analysis and reverse engineering verification of SNZ3Biotechnology for biofuels and bioproducts · 2025
    Article

86 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Ryan A LaCroixDepartment of Bioengineering, University of California, San Diego, La Jolla, California, USA.
Troy E SandbergDepartment of Bioengineering, University of California, San Diego, La Jolla, California, USA.
Edward J O'BrienDepartment of Bioengineering, University of California, San Diego, La Jolla, California, USA.
Jose UtrillaDepartment of Bioengineering, University of California, San Diego, La Jolla, California, USA.
Ali EbrahimDepartment of Bioengineering, University of California, San Diego, La Jolla, California, USA.
Gabriela I GuzmanDepartment of Bioengineering, University of California, San Diego, La Jolla, California, USA.
Richard SzubinDepartment of Bioengineering, University of California, San Diego, La Jolla, California, USA.
Bernhard O PalssonDepartment of Bioengineering, University of California, San Diego, La Jolla, California, USA Novo Nordisk Foundation Center for Biosustainability, Technical University of Denmark, Lyngby, Denmark Department of Pediatrics, University of California, San Diego, La Jolla, California, USA.
Adam M FeistDepartment of Bioengineering, University of California, San Diego, La Jolla, California, USA Novo Nordisk Foundation Center for Biosustainability, Technical University of Denmark, Lyngby, Denmark afeist@ucsd.edu.
University of California, San Diego · USNovo Nordisk Foundation · DKTechnical University of Denmark · DK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Adaptive laboratory evolution (ALE) has emerged as an effective tool for scientific discovery and addressing biotechnological needs. Much of ALE's utility is derived from reproducibly obtained fitness increases. Identifying causal genetic changes and their combinatorial effects is challenging and time-consuming. Understanding how these genetic changes enable increased fitness can be difficult. A series of approaches that address these challenges was developed and demonstrated using Escherichia coli K-12 MG1655 on glucose minimal media at 37°C. By keeping E. coli in constant substrate excess and exponential growth, fitness increases up to 1.6-fold were obtained compared to the wild type. These increases are comparable to previously reported maximum growth rates in similar conditions but were obtained over a shorter time frame. Across the eight replicate ALE experiments performed, causal mutations were identified using three approaches: identifying mutations in the same gene/region across replicate experiments, sequencing strains before and after computationally determined fitness jumps, and allelic replacement coupled with targeted ALE of reconstructed strains. Three genetic regions were most often mutated: the global transcription gene rpoB, an 82-bp deletion between the metabolic pyrE gene and rph, and an IS element between the DNA structural gene hns and tdk. Model-derived classification of gene expression revealed a number of processes important for increased growth that were missed using a gene classification system alone. The methods described here represent a powerful combination of technologies to increase the speed and efficiency of ALE studies. The identified mutations can be examined as genetic parts for increasing growth rate in a desired strain and for understanding rapid growth phenotypes.

Indexed as

Adaptation, BiologicalMutationCulture MediaEscherichia coli K12Escherichia coli ProteinsGene Expression ProfilingGlucoseMolecular Sequence DataSequence Analysis, DNATemperatureCulture MediaEscherichia coli ProteinsGlucose

Identifiers

PMID25304508
PMCPMC4272732
OpenAlexW2144068357

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.